Prostate

Prostatic adenocarcinoma

The commonest non-skin cancer of elderly men, usually in the posterior (peripheral) prostate; graded by the Gleason system, detected by PSA and biopsy, and spreading to pelvic nodes and the vertebrae.

Causes and risk factors

Gross pathology

Under the microscope

How it develops

Complications

Investigations

Prostate-specific antigen (PSA)
Often raised; used to detect and follow the disease, though not specific to cancer.
Multiparametric MRI
Shows suspicious areas and guides biopsy.
Prostate biopsy
Confirms carcinoma; the Gleason score (Grade Group) measures how abnormal the glands are.
Bone scan or PSMA PET
Metastases, which in bone are typically osteoblastic (bone-forming).

Drug treatment

Drugs to avoid or use with care

Anatomy involved

Connected topics

Written from

Educational reference. Not medical advice, diagnosis or treatment.